Brief: Vistagen Therapeutics CFO Cynthia L. Anderson Resigns - SEC Filing
15/09/2025 23:25
Sept 15 (Reuters) - SEC Filing: VISTAGEN THERAPEUTICS INC - CFO CYNTHIA L. ANDERSON RESIGNS EFFECTIVE OCTOBER 15, 2025 - SEC FILING VISTAGEN THERAPEUTICS INC - CONDUCTING SEARCH FOR NEW CFO - SEC FILING Source text: [ID:n0001411685-25-000081] Further company coverage: VTGN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vistagen Therapeutics
See all newsBrief: Vistagen TherapeuticsSays Fasedienol Nasal Spray Well-Tolerated With No New Drug-Related Safety Findings After 12 Months
VistaGen Q1 revenue rises on licensing agreement expiration
Brief: VistaGen Q1 EPS USD -0.3
Vistagen Therapeutics Inc expected to post a loss of 36 cents a share - Earnings Preview
Brief: Vistagen Appoints Douglas J. Williamson To Its Board Of Directors